NextFin

ARKK Sells $27M in CRISPR and Tesla While Adding $16M in Palantir

Summarized by NextFin AI
  • ARKK ETF maintained stability in holdings between 2026-03-05 and 2026-03-06, with no recorded buy or sell activities.
  • Weekly position changes revealed strategic adjustments, with significant sells in CRISPR Therapeutics AG and Tesla Inc, indicating active management by ARK Invest.
  • Portfolio adjustments included a buy in Palantir Technologies Inc and Coinbase Global Inc, reflecting confidence in innovation-driven companies.
  • Market context showed moderate volatility, particularly in technology and biotech sectors, influencing ARKK's trading strategy.

ARKK Daily Position Changes Report - 2026-03-06

Overview:

ARKK ETF showed no changes in holdings between 2026-03-05 and 2026-03-06. All top holdings maintained their positions with identical portfolio weights and values.

Detailed Summary:

On 2026-03-06, ARKK's holdings remained unchanged from the previous trading day. Major holdings such as Tesla Inc, CRISPR Therapeutics AG, Tempus AI Inc-A, Shopify Inc-A, and others maintained their portfolio weights and market values without any recorded buy or sell activities.

Analysis and Interpretation:

The absence of position changes indicates a holding pattern by ARK Invest on 2026-03-06. This stability in portfolio composition could suggest a strategic pause in trading, possibly reflecting a wait-and-see stance amid current market conditions or confidence in the existing portfolio allocations. No trades were detected in the top 10 holdings, implying no immediate adjustments to ARKK's innovation-driven investment thesis on this day.

Position Changes Table:

Ticker Company Name Direction Shares Traded Estimated Trade Value ($) % of Portfolio Change
No position changes recorded

ARKK Weekly Position Changes Report - Week Ending 2026-03-06

Overview:

ARKK ETF exhibited measurable position changes during the week ending 2026-03-06, reflecting strategic portfolio adjustments following the last trading day of the previous week (2026-02-28). Several key holdings showed significant buy or sell activity, impacting the overall portfolio composition.

Weekly Summary:

Over the week, ARKK increased its exposure to some core innovation-driven companies while reducing or exiting others. Notably, Tesla Inc, CRISPR Therapeutics AG, and Tempus AI Inc-A demonstrated meaningful shifts in portfolio weight and value. Position changes indicate ARK Invest's active management approach to capitalize on evolving market conditions and innovation trends.

Net Cumulative Changes for Key Holdings (Top 10 by Trade Value):

  • CRSP (CRISPR Therapeutics AG): Sell of $-27,622,639.36 with portfolio weight change of -0.211%.
  • TSLA (Tesla Inc): Sell of $-27,288,945.70 with portfolio weight change of -0.101%.
  • TEM (Tempus AI Inc-A): Sell of $-25,669,822.52 with portfolio weight change of -0.232%.
  • ROKU (Roku Inc-A): Sell of $-25,429,295.73 with portfolio weight change of -0.248%.
  • PLTR (0): Buy of $16,637,616.48 with portfolio weight change of +0.351%.
  • BEAM (Beam Therapeutics Inc): Sell of $-14,675,073.20 with portfolio weight change of -0.111%.
  • TWST (Twist Bioscience Corp): Sell of $-7,800,740.02 with portfolio weight change of -0.035%.
  • SHOP (Shopify Inc-A): Sell of $-5,400,371.72 with portfolio weight change of +0.057%.
  • COIN (Coinbase Global Inc-A): Buy of $5,145,172.44 with portfolio weight change of +0.207%.
  • TXG (10x Genomics Inc-A): Buy of $3,554,015.08 with portfolio weight change of +0.130%.

Top 5 Buys:

Ticker Company Name Direction Shares Traded Estimated Trade Value ($) % of Portfolio Change
PLTR 0 Buy N/A $16,637,616.48 +0.351%
COIN Coinbase Global Inc-A Buy N/A $5,145,172.44 +0.207%
TXG 10x Genomics Inc-A Buy N/A $3,554,015.08 +0.130%

Top 5 Sells:

Ticker Company Name Direction Shares Traded Estimated Trade Value ($) % of Portfolio Change
CRSP CRISPR Therapeutics AG Sell N/A $-27,622,639.36 -0.211%
TSLA Tesla Inc Sell N/A $-27,288,945.70 -0.101%
TEM Tempus AI Inc-A Sell N/A $-25,669,822.52 -0.232%
ROKU Roku Inc-A Sell N/A $-25,429,295.73 -0.248%
BEAM Beam Therapeutics Inc Sell N/A $-14,675,073.20 -0.111%

Analysis and Interpretation:

The weekly position changes reflect ARK Invest's tactical adjustments in response to market dynamics and company-specific developments. Buying activity in high-conviction names may signal confidence in their growth prospects, while sells could represent risk management or profit-taking measures. The focused alterations amongst ARKK's top holdings suggest a nuanced rebalancing rather than wholesale portfolio shifts.

Market Context:

During this week, broader market conditions showed moderate volatility especially in the technology and biotech sectors. ARKK's trading activity aligns with attempts to position the fund advantageously amid sector rotation and innovation-driven opportunities.

Position Changes Summary Table:

Ticker Company Name Direction Shares Traded Estimated Trade Value ($) % of Portfolio Change
CRSP CRISPR Therapeutics AG Sell N/A $-27,622,639.36 -0.211%
TSLA Tesla Inc Sell N/A $-27,288,945.70 -0.101%
TEM Tempus AI Inc-A Sell N/A $-25,669,822.52 -0.232%
ROKU Roku Inc-A Sell N/A $-25,429,295.73 -0.248%
PLTR 0 Buy N/A $16,637,616.48 +0.351%
BEAM Beam Therapeutics Inc Sell N/A $-14,675,073.20 -0.111%
TWST Twist Bioscience Corp Sell N/A $-7,800,740.02 -0.035%
SHOP Shopify Inc-A Sell N/A $-5,400,371.72 +0.057%
COIN Coinbase Global Inc-A Buy N/A $5,145,172.44 +0.207%
TXG 10x Genomics Inc-A Buy N/A $3,554,015.08 +0.130%

Explore more exclusive insights at nextfin.ai.

Insights

What are the key strategies employed by ARK Invest in managing ARKK's portfolio?

How does ARKK's investment approach differ from traditional ETFs?

What factors contributed to ARKK's decision to sell CRISPR and Tesla stocks?

What does the recent sell-off in ARKK's top holdings indicate about market conditions?

How has user feedback been regarding ARKK's performance over recent months?

What innovations are driving ARKK's investment thesis in 2026?

What recent updates have been made to ARK Invest's investment policies?

How might ARKK evolve its strategy in response to changing market dynamics?

What challenges does ARK Invest face in maintaining portfolio performance?

What controversies have arisen from ARKK's investment choices recently?

How do ARKK's recent trades compare to those of its competitors?

What historical trends can be observed in ARKK's trading patterns?

How does ARKK's investment in Palantir reflect current industry trends?

What implications do ARKK's recent trades have for its long-term investment strategy?

What role does market volatility play in ARKK's investment decisions?

How do changes in the biotech sector affect ARKK's portfolio composition?

What are the key performance metrics used to evaluate ARKK's holdings?

What are the potential long-term effects of ARK's recent trades on investor sentiment?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App